Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ioanna Gioni"'
Autor:
Angel Luis Martín de Francisco, Iain Andrew Gillespie, Ioanna Gioni, Jürgen Floege, Florian Kronenberg, Daniele Marcelli, David Collins. Wheeler, Marc Froissart, Tilman Bernhard. Drueke
Publikováno v:
Nefrología (English Edition), Vol 36, Iss 2, Pp 164-175 (2016)
Background: Anti-parathyroid treatment initiation and discontinuation are important decisions in chronic haemodialysis (HD) patients, where pill burden is often excessive. The present study aimed to describe secondary hyperparathyroidism (sHPT) drug
Externí odkaz:
https://doaj.org/article/3e67d12520f9497db8de155da207e5f5
Autor:
Sarit Cohen-Rabbie, Diansong Zhou, Stein Schalkwijk, Ioanna Gioni, Karthick Vishwanathan, Li Zhou, Karen So, Zhongqing He, Helen Tomkinson, Tomoko Freshwater, Lokesh Jain
Publikováno v:
Cancer Chemotherapy and Pharmacology. 88:189-202
Selumetinib (ARRY-142886) is a potent, selective, MEK1/2 inhibitor approved in the US for the treatment of children (≥ 2 years) with neurofibromatosis type 1 (NF1) and symptomatic, inoperable plexiform neurofibromas (PN). We characterized populatio
Autor:
David C. Wheeler, Marc Froissart, Stefan D. Anker, Yumi Kubo, Iain A. Gillespie, Tilman B. Drüeke, Angel L.M. de Francisco, Jürgen Floege, Ioanna Gioni
Publikováno v:
Pharmacoepidemiology and Drug Safety, 2014, 24, 738-747
Pharmacoepidemiology and Drug Safety
Pharmacoepidemiology and Drug Safety
Purpose: The generalisability of randomised controlled trials (RCTs) may be limited by restrictive entry criteria or by their experimental nature. Observational research can provide complementary findings but is prone to bias. Employing propensity sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02524f78f346ebbb671c331ac9fc261b
http://resolver.sub.uni-goettingen.de/purl?gs-1/13838
http://resolver.sub.uni-goettingen.de/purl?gs-1/13838
Autor:
Stefan D. Anker, Marc Froissart, Ioanna Gioni, Bruce M. Robinson, Kai-Uwe Eckardt, Iain A. Gillespie, Daniele Marcelli, Florian Kronenberg, Sharon Richards, Jürgen Floege, Ronald L. Pisoni
Publikováno v:
Kidney international 87(5), 996-1008 (2015). doi:10.1038/ki.2014.419
Kidney International
Kidney International
Although mortality risk scores for chronic hemodialysis (HD) patients should have an important role in clinical decision-making, those currently available have limited applicability, robustness, and generalizability. Here we applied a modified Framin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd3613ffacecca57a6960e8d78aa721e
Autor:
Yumi Kubo, Karminder Gill, Patrick S. Parfrey, Marie-Louise Trotman, Glenn M. Chertow, Bastian Dehmel, Lulu Ren Sterling, Ioanna Gioni, Kenneth W. Mahaffey
Publikováno v:
Pharmaceutical statistics. 14(3)
Intention-to-treat (ITT) analysis is widely used to establish efficacy in randomized clinical trials. However, in a long-term outcomes study where non-adherence to study drug is substantial, the on-treatment effect of the study drug may be underestim
Autor:
Dominic Mitchell, Louise Perrault, Ioanna Gioni, Caroline Mattin, Vasily Belozeroff, Silvia Chiroli
Publikováno v:
BMC Nephrology
BMC Nephrology, Vol 13, Iss 1, p 140 (2012)
BMC Nephrology, Vol 13, Iss 1, p 140 (2012)
Background Secondary hyperparathyroidism (SHPT) is associated with mortality in patients with chronic kidney disease (CKD), but the economic consequences of SHPT have not been adequately studied in the European population. We assessed the relationshi